Anhui, China

Xiaochuan Liu

This inventor holds 1 USPTO granted patent. Top assignees: Hefei Gracevo Bio-Medicine Co., Ltd, Precedo Pharmaceuticals Co., Ltd. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaochuan Liu. Retrieved from https://idiyas.com/inventor/xiaochuan-liu-jjv0i2ce

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaochuan Liu

Introduction

Xiaochuan Liu is a notable inventor based in Anhui, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. His work focuses on addressing diseases related to the activity of tyrosine kinase C-KIT.

Latest Patents

Xiaochuan Liu holds a patent for a Selective C-KIT kinase inhibitor. The present invention provides a compound represented by formula (I), or a pharmaceutically acceptable salt, a solvate, an ester, an acid, a metabolite, or a prodrug thereof. This compound can be utilized in combination with at least one therapeutic agent for preventing or treating diseases, disorders, or symptoms caused by the adjustment of the activity of tyrosine kinase C-KIT, especially cancers or other cell proliferation diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Xiaochuan Liu has worked with various companies, including Precedo Pharmaceuticals Co., Ltd and Hefei Gracevo Bio-medicine Co., Ltd. His experience in these organizations has contributed to his expertise in the pharmaceutical industry.

Collaborations

Xiaochuan Liu has collaborated with notable individuals in his field, including Qingsong Liu and Jing Liu. These partnerships have likely enhanced his research and development efforts.

Conclusion

Xiaochuan Liu's innovative work in the field of kinase inhibitors showcases his dedication to advancing medical science. His contributions are significant in the ongoing fight against diseases related to tyrosine kinase C-KIT.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…